Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 348

Goldman gets into the Kno

Goldman and GSV line up with US media company Advance Publications and Intel Capital backing the start-up founded by repeat entrepreneur Osman Rashid.

Jun 13, 2011

Salesforce pumps up ServiceMax

ServiceMax, a provider of mobile field service applications formerly known as Maxplore Technologies, has raised $14m in its series C round from a consortium including online software group Salesforce.com.

Jun 13, 2011

Violin Memory strings together $40m

Corporate venturing-backed data storage company Violin Memory raised $40m at a $440m valuation, while peer Fusion-io floated in New York.

Jun 10, 2011

Cisco-backed Act-On raises $10m

Other C-round backers of Act-On Software, a US-based provider of online marketing services, are venture capital firms Trinity Ventures, US Venture Partners and Voyager Capital.

Jun 6, 2011

Syngenta, Mitsui join Marrone fertiliser deal

Alongside Syngenta Ventures and Mitsui Global Investment were an undisclosed family investment trust and existing venture capital investors Stuart Mill Venture Partners, Contrarian Group, Saffron Hill Ventures, One Earth Capital, Clean Pacific Ventures and Calvert Social Ventures.

Jun 3, 2011

Six Degrees Games times another $4m

Time Warner-backed Six Degrees Games raises C round.

May 27, 2011

Ipsen breaks wishbone with Radius

At the initial closing of the financing, Radius received gross proceeds of $22m in equity and $6.25m in debt, and $1.4m of preferred stock was issued to Ipsen in lieu of a cash milestone payment.

May 27, 2011

TetraLogic Pharma gains $6m

In September, Pfizer through its corporate venturing unit invested $5m in TetraLogic.

May 27, 2011

GenKyoTex signs up MP

Takahiro Mukahira of MP Healthcare Venture Management will be a board observer at GenKyoTex.

May 27, 2011

Tepha starts C round with $5m

The company said its investors in its series A and B rounds, which raised $15m in total, including from Switzerland-based drugs company Novartis' corporate venturing fund, and venture capital firms Vertical Group, Integra Ventures and Westfield Life Sciences Fund.

May 27, 2011
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here